Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 08:00 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Avoro Capital Advisors LLC | 8,000,000 8.2% | 2,750,000 (+52.38%) | View |
| 2021-01-28 5:56 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BlackRock Inc. BLK | 7,042,768 7.2% | 2,524,335 (+55.87%) | View |
| 2020-12-23 5:17 pm Sale | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Versant Ventures IV LLC | 5,003,892 5.1% | -2,000,000 (-28.56%) | View |
| 2020-08-20 2:21 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 4,247,281 4.4% | 451,715 (+11.90%) | View |
| 2020-02-14 1:31 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RTW INVESTMENTS LP | 6,386,607 9.89% | 129,767 (+2.07%) | View |
| 2020-02-14 12:00 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | ORBIMED ADVISORS LLC | 3,944,090 6.11% | 3,944,090 (New Position) | View |
| 2020-02-14 10:13 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Avoro Capital Advisors LLC | 5,250,000 8.1% | 5,250,000 (New Position) | View |
| 2020-02-13 4:16 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RENAISSANCE TECHNOLOGIES LLC | 1,455,848 2.25% | -2,261,919 (-60.84%) | View |
| 2020-02-12 4:04 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,000,000 1.55% | -2,500,000 (-71.43%) | View |
| 2020-02-05 11:26 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BlackRock Inc. BLK | 4,518,433 7% | 74,463 (+1.68%) | View |
| 2019-05-30 12:16 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,500,000 5.52% | 500,000 (+16.67%) | View |
| 2019-05-03 4:21 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 3,795,566 6% | 300,000 (+8.58%) | View |